6571 POSTER Impact of Prior Somatostatin Analog (SSA) Use on PFS in the Multicenter, Phase III Trial of Everolimus + Octreotide LAR Vs Placebo + Octreotide LAR in Patients With Advanced Neuroendocrine Tumours (RADIANT-2)

✍ Scribed by Pavel, M.; Singh, N.; Passos, V.; Oberg, K.

• Book ID: 123161164
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 61 KB
• Volume: 47
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(11)71882-2